These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2353440)

  • 1. Pharmacokinetics: regulatory aspects. Point of view of FDA.
    Teske RH; Newkirk DR
    Vet Hum Toxicol; 1990 Jun; 32(3):261-2. PubMed ID: 2353440
    [No Abstract]   [Full Text] [Related]  

  • 2. AAPS-FDA Workshop White Paper: microdialysis principles, application, and regulatory perspectives.
    Chaurasia CS; Müller M; Bashaw ED; Benfeldt E; Bolinder J; Bullock R; Bungay PM; DeLange EC; Derendorf H; Elmquist WF; Hammarlund-Udenaes M; Joukhadar C; Kellogg DL; Lunte CE; Nordstrom CH; Rollema H; Sawchuk RJ; Cheung BW; Shah VP; Stahle L; Ungerstedt U; Welty DF; Yeo H
    J Clin Pharmacol; 2007 May; 47(5):589-603. PubMed ID: 17442685
    [No Abstract]   [Full Text] [Related]  

  • 3. The drug approval process and the FDA.
    Schmidt AM
    Conn Med; 1975 Apr; 39(4):237-40. PubMed ID: 1149447
    [No Abstract]   [Full Text] [Related]  

  • 4. The FDA perspective on the development of stereoisomers.
    De Camp WH
    Chirality; 1989; 1(1):2-6. PubMed ID: 2642032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restrictions on antibiotics proposed by the FDA: a practitioner's point of view.
    Blohm WD
    Vet Med Small Anim Clin; 1978 May; 73(5):558, 560, 562, passim. PubMed ID: 249153
    [No Abstract]   [Full Text] [Related]  

  • 6. Opioid peptides as drug products: FDA regulatory requirements.
    Hoiberg CP; Rapaka RS
    NIDA Res Monogr; 1986; 70():385-404. PubMed ID: 3093882
    [No Abstract]   [Full Text] [Related]  

  • 7. How bad the drug lag?
    Clark M; Hager M; Gosnell M
    Newsweek; 1978 Oct; 92(15):119, 121. PubMed ID: 10297213
    [No Abstract]   [Full Text] [Related]  

  • 8. Current position of the F&DA regarding veterinary drug and feed additive registration in the USA.
    Leaning WH
    J S Afr Vet Assoc; 1981 Mar; 52(1):51-6. PubMed ID: 7265103
    [No Abstract]   [Full Text] [Related]  

  • 9. Critics fear the FDA is going too far in cutting industry's regulatory load.
    Demkovich LE
    Natl J (Wash); 1982 Jul; 14(29):1249-52. PubMed ID: 10255878
    [No Abstract]   [Full Text] [Related]  

  • 10. Development of a course of study in FDA drug regulatory procedures.
    Jacobs RW; King JC
    Am J Pharm Educ; 1977 May; 41(2):185-88. PubMed ID: 10236647
    [No Abstract]   [Full Text] [Related]  

  • 11. The US Food and Drug Administration and probiotics: regulatory categorization.
    Degnan FH
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S133-6; discussion S144-51. PubMed ID: 18181719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug regulation and policy formulation.
    Nightingale SL
    Milbank Mem Fund Q Health Soc; 1981; 59(3):412-44. PubMed ID: 7024847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDA regulatory compliance reconsidered.
    Tobias C
    Cornell Law Rev; 2008 Jul; 93(5):1003-38. PubMed ID: 18618969
    [No Abstract]   [Full Text] [Related]  

  • 14. Guidance for industry on Population Pharmacokinetics; availability. Food and Drug Administration, HHS. Notice.
    Fed Regist; 1999 Feb; 64(27):6663-4. PubMed ID: 10557596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FDA under attack.
    Mod Vet Pract; 1981 Mar; 62(3):197-201. PubMed ID: 7207445
    [No Abstract]   [Full Text] [Related]  

  • 16. Professional responsibilities.
    Jenkins WL
    J Am Vet Med Assoc; 1993 May; 202(10):1742-3. PubMed ID: 8514601
    [No Abstract]   [Full Text] [Related]  

  • 17. Pre-approval inspection program for drugs.
    Meyer GF
    J Parenter Sci Technol; 1992; 46(3):98-9. PubMed ID: 1522448
    [No Abstract]   [Full Text] [Related]  

  • 18. A few thoughts on the development and regulation of neuropeptides.
    Gueriguian JL; Chiu YY
    NIDA Res Monogr; 1986; 70():405-14. PubMed ID: 3093883
    [No Abstract]   [Full Text] [Related]  

  • 19. Decision on Aspartame due this year.
    Holden C
    Science; 1980 Feb; 207(4433):856-7. PubMed ID: 7355267
    [No Abstract]   [Full Text] [Related]  

  • 20. An overview of current programs on drug development and regulation for small ruminants--pharmaceutical industry perspective.
    Terry M
    Vet Hum Toxicol; 1993; 35 Suppl 2():12-3. PubMed ID: 8236759
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.